| scholarly article | Q13442814 |
| P2093 | author name string | Ting Li | |
| Zheng Wang | |||
| Jia Li | |||
| Weidong Le | |||
| Yu Tang | |||
| Xiao-Jie Zhang | |||
| P2860 | cites work | Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models | Q39924456 |
| Hypoxia increases Abeta generation by altering beta- and gamma-cleavage of APP. | Q40038717 | ||
| Effects of hypoxia and oxidative stress on expression of neprilysin in human neuroblastoma cells and rat cortical neurones and astrocytes | Q40135781 | ||
| Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation | Q40170530 | ||
| Effect of ischemic neuronal insults on amyloid precursor protein processing | Q40263442 | ||
| Hypoxic regulation of telomerase gene expression by transcriptional and post-transcriptional mechanisms | Q40371754 | ||
| Neprilysin regulates amyloid Beta peptide levels | Q40595769 | ||
| Valproic acid stimulates clusterin expression in human astrocytes: Implications for Alzheimer's disease | Q43121979 | ||
| Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2'-deoxycytidine | Q44220740 | ||
| Dependence of histone modifications and gene expression on DNA hypermethylation in cancer. | Q44260410 | ||
| Presenilin 1 gene silencing by S‐adenosylmethionine: a treatment for Alzheimer disease? | Q44411058 | ||
| Cerebrospinal fluid neprilysin is reduced in prodromal Alzheimer's disease | Q44446243 | ||
| Prenatal hypoxia may aggravate the cognitive impairment and Alzheimer's disease neuropathology in APPSwe/PS1A246E transgenic mice | Q47385458 | ||
| Valproic acid attenuates neuronal loss in the brain of APP/PS1 double transgenic Alzheimer's disease mice model | Q48350023 | ||
| Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy | Q48404228 | ||
| A comparative study of modified Bielschowsky, Bodian and thioflavin S stains on Alzheimer's neurofibrillary tangles | Q48424499 | ||
| The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation | Q48486318 | ||
| Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins | Q48601563 | ||
| Transcriptional regulation of APH-1A and increased gamma-secretase cleavage of APP and Notch by HIF-1 and hypoxia. | Q53378635 | ||
| Analysis of the human CD10/neutral endopeptidase 24.11 promoter region: two separate regulatory elements | Q72252440 | ||
| Tissue-specific expression of rat neutral endopeptidase (neprilysin) mRNAs | Q72631526 | ||
| [Impact of treatment with acetylcholinesterase inhibitors, valproic acid and antipsychotics on aggressive behaviour in Alzheimer's type dementia] | Q95431091 | ||
| DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development | Q22010765 | ||
| Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex | Q24324026 | ||
| Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder | Q24652360 | ||
| The amyloid precursor protein: beyond amyloid | Q24680465 | ||
| Etiology of sporadic Alzheimer's disease: somatostatin, neprilysin, and amyloid beta peptide | Q28253290 | ||
| Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein | Q29547803 | ||
| The blood-brain barrier: an overview: structure, regulation, and clinical implications | Q29616839 | ||
| Recovery of learning and memory is associated with chromatin remodelling | Q29619784 | ||
| The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease | Q30432239 | ||
| Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center | Q30982265 | ||
| Hypoxia-induced down-regulation of neprilysin by histone modification in mouse primary cortical and hippocampal neurons | Q33895062 | ||
| The new generation of GABA enhancers. Potential in the treatment of epilepsy | Q34320951 | ||
| Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases? | Q34687570 | ||
| Hypoxia signaling to genes: significance in Alzheimer's disease | Q34995070 | ||
| Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression | Q35214758 | ||
| Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease. | Q36512147 | ||
| Update on hypertension and Alzheimer's disease | Q36582774 | ||
| Enhanced clearance of Abeta in brain by sustaining the plasmin proteolysis cascade | Q36735157 | ||
| Neuropsychiatric and behavioral aspects of trisomy 21. | Q36772007 | ||
| How and when environmental agents and dietary factors affect the course of Alzheimer's disease: the "LEARn" model (latent early-life associated regulation) may explain the triggering of AD. | Q36789936 | ||
| Histone deacetylases: focus on the nervous system | Q36832256 | ||
| DNA (cytosine-5)-methyltransferases in mouse cells and tissues. Studies with a mechanism-based probe. | Q36873208 | ||
| Molecular and cellular mechanisms for Alzheimer's disease: understanding APP metabolism | Q37017923 | ||
| Amyloid-degrading enzymes as therapeutic targets in Alzheimer's disease | Q37130677 | ||
| Neprilysin and amyloid beta peptide degradation | Q37130680 | ||
| Pathological role of hypoxia in Alzheimer's disease | Q37579332 | ||
| The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth | Q38299684 | ||
| Relation of cerebral infarctions to dementia and cognitive function in older persons | Q38428811 | ||
| Valproate reduces tau phosphorylation via cyclin-dependent kinase 5 and glycogen synthase kinase 3 signaling pathways | Q39571186 | ||
| Valproic acid enhances microglial phagocytosis of amyloid-beta(1-42). | Q39710191 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 209-217 | |
| P577 | publication date | 2013-12-02 | |
| P1433 | published in | CNS Neuroscience & Therapeutics | Q5013184 |
| P1476 | title | Valproic acid reduces neuritic plaque formation and improves learning deficits in APP(Swe) /PS1(A246E) transgenic mice via preventing the prenatal hypoxia-induced down-regulation of neprilysin. | |
| P478 | volume | 20 |
| Q48225902 | (-)-Epigallocatechin-3-gallate attenuates cognitive deterioration in Alzheimer's disease model mice by upregulating neprilysin expression. |
| Q60045614 | 5-HIAA induces neprilysin to ameliorate pathophysiology and symptoms in a mouse model for Alzheimer's disease |
| Q61811401 | Age-related Disturbances in DNA (hydroxy)methylation in APP/PS1 Mice |
| Q47578572 | Age-related epigenetic changes in hippocampal subregions of four animal models of Alzheimer's disease. |
| Q38256360 | Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer's disease |
| Q92596034 | Bidirectional relationship between sleep and Alzheimer's disease: role of amyloid, tau, and other factors |
| Q27024122 | Drug repositioning approaches for the discovery of new therapeutics for Alzheimer's disease |
| Q41568885 | Effect of pregabalin on contextual memory deficits and inflammatory state-related protein expression in streptozotocin-induced diabetic mice. |
| Q37714817 | Epigenetic modifications of chronic hypoxia-mediated neurodegeneration in Alzheimer's disease |
| Q48005072 | Gender difference in valproic acid-induced neuroprotective effects on APP/PS1 double transgenic mice modeling Alzheimer's disease |
| Q38601445 | Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications |
| Q47732984 | Long-lasting recognition memory impairment and alterations in brain levels of cytokines and BDNF induced by maternal deprivation: effects of valproic acid and topiramate |
| Q38684428 | Neuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs |
| Q59795302 | Role of Prenatal Hypoxia in Brain Development, Cognitive Functions, and Neurodegeneration |
| Q96018023 | Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost |
| Q50707979 | Valproic Acid Modifies Synaptic Structure and Accelerates Neurite Outgrowth Via the Glycogen Synthase Kinase-3β Signaling Pathway in an Alzheimer's Disease Model. |
| Q64117819 | Valproic Acid Stimulates Hippocampal Neurogenesis Activating the Wnt/β-Catenin Signaling Pathway in the APP/PS1/Nestin-GFP Triple Transgenic Mouse Model of Alzheimer's Disease |
| Q48773223 | Valproic acid alleviates memory deficits and attenuates amyloid-β deposition in transgenic mouse model of Alzheimer's disease |
| Q48351124 | Valproic acid-mediated inhibition of trimethyltin-induced deficits in memory and learning in the rat does not directly depend on its anti-oxidant properties. |
| Q64986754 | Vascular Dysfunction in Alzheimer's Disease: A Prelude to the Pathological Process or a Consequence of It? |
| Q64991185 | What are the links between hypoxia and Alzheimer's disease? |
Search more.